News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Antibe Therapeutics Inc. Completes Second Closing Of Non-Brokered Private Placement Bringing Total Proceeds To $3,925,358



4/7/2014 10:07:03 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc. (“Antibe” or the “Corporation”) (TSXV:ATE) has completed a second closing of its previously announced non-brokered private placement raising gross proceeds of $909,960 (the "Offering") on the sale of 1,519,600 Common Shares of the Corporation, bringing the total gross proceeds of this raise to $3,925,358.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES